These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2825657)

  • 41. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.
    Farmer T; Reading C
    Drugs; 1986; 31 Suppl 3():70-8. PubMed ID: 3488199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of inhibition of RTEM-2 beta-lactamase by cephamycins: relative importance of the 7 alpha-methoxy group and the 3' leaving group.
    Faraci WS; Pratt RF
    Biochemistry; 1986 May; 25(10):2934-41. PubMed ID: 3487346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine.
    Sigal IS; DeGrado WF; Thomas BJ; Petteway SR
    J Biol Chem; 1984 Apr; 259(8):5327-32. PubMed ID: 6425288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346.
    Sawai T; Yamaguchi A; Tsukamoto K
    Rev Infect Dis; 1988; 10(4):721-5. PubMed ID: 3263684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative in vitro inhibitory activities of novel beta-lactam compounds against multiresistant beta-lactamase producing Staphylococcus aureus.
    Ray B; Panja K; Bal M
    Indian J Med Res; 1986 May; 83():453-7. PubMed ID: 3015791
    [No Abstract]   [Full Text] [Related]  

  • 50. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.
    Christensen H; Martin MT; Waley SG
    Biochem J; 1990 Mar; 266(3):853-61. PubMed ID: 2158301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F; Williams J; Yamabe S
    Chemioterapia; 1987 Jun; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract]   [Full Text] [Related]  

  • 52. The beta-lactamase of Enterobacter cloacae P99. Chemical properties, N-terminal sequence and interaction with 6 beta-halogenopenicillanates.
    Joris B; De Meester F; Galleni M; Reckinger G; Coyette J; Frere JM; Van Beeumen J
    Biochem J; 1985 May; 228(1):241-8. PubMed ID: 2988516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.
    De Meester F; Frère JM; Waley SG; Cartwright SJ; Virden R; Lindberg F
    Biochem J; 1986 Nov; 239(3):575-80. PubMed ID: 3030266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
    Gottstein WJ; Crast LB; Graham RG; Haynes UJ; McGregor DN
    J Med Chem; 1981 Dec; 24(12):1531-4. PubMed ID: 6273562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.
    Fisher J; Charnas RL; Knowles JR
    Biochemistry; 1978 May; 17(11):2180-4. PubMed ID: 352394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate.
    Neu HC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):63-6. PubMed ID: 6299186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
    Kemal C; Knowles JR
    Biochemistry; 1981 Jun; 20(13):3688-95. PubMed ID: 6268141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies.
    Chen CC; Herzberg O
    J Mol Biol; 1992 Apr; 224(4):1103-13. PubMed ID: 1569569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thiol-beta-lactamase: replacement of the active-site serine of RTEM beta-lactamase by a cysteine residue.
    Sigal IS; Harwood BG; Arentzen R
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7157-60. PubMed ID: 6818541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.